List view / Grid view
1 June 2017 | By Niamh Marriott, Junior Editor
The European Medicines Agency (EMA) has approved Aptar Pharma’s integrated electronic nasal lockout device (e-Lockout) following a partnership with Takeda.
1 June 2017 | By Niamh Marriott, Junior Editor
Atlantic Healthcare announces the development of two separate tablet formulations of alicaforsen, for targeted delivery in the GI tract...
1 June 2017 | By Niamh Marriott, Junior Editor
Emblem has agreed to purchase land in preparation for the anticipated demand stemming from the proposed legalisation of adult recreational use in Canada...
1 June 2017 | By Niamh Marriott, Junior Editor
The European Medicines Agency (EMA) and the European Commission have published an information guide for healthcare professionals on biosimilar medicines...
31 May 2017 | By Niamh Marriott, Junior Editor
In a small, randomised Phase I/II clinical trial, researchers at UC San Diego School of Medicine say a 100-year-old drug called suramin...
31 May 2017 | By 42Gears Mobility Systems
42Gears recently worked with Alkem Laboratories, one of the biggest Indian pharmaceutical companies, to help secure on-field mobile devices from misuse and to enhance workforce productivity.
31 May 2017 | By Niamh Marriott, Junior Editor
The US Food and Drug Administration has approved the first generic versions of Strattera (atomoxetine) to treat (ADHD) in pediatric and adult patients...
30 May 2017 | By American College of Physicians
Stepping up to biologic therapy offers minimal incremental benefit over using a combination of drugs known as triple therapy, yet incurs large costs...
30 May 2017 | By Quotient Clinical
Appointment supports Quotient’s strategy to further develop its global commercial footprint following two recent US acquisitions...
30 May 2017 | By Niamh Marriott, Junior Editor
The US Food and Drug Administration (FDA) approved the expanded use of Novartis’ Zykadia (ceritinib) to include patients with NSCLC...
26 May 2017 | By F.P.S. Food and Pharma Systems Srl
FPS has recently delivered a high containment Integrated systems for an Oncology plant in Bangalore...
26 May 2017 | By Niamh Marriott, Junior Editor
A trial led by a McMaster University respirology professor shows promising results for a new medicine for severe asthma patients.
26 May 2017 | By Niamh Marriott, Junior Editor
The FDA has granted Orphan Drug Designation for Abeona Therapeutics’s EB-101 gene therapy program for patients with dystrophic epidermolysis bullosa...
25 May 2017 | By Niamh Marriott, Junior Editor
A pioneering medical technology firm has launched a unique manufacturing facility to extract collagen from jellyfish.
25 May 2017 | By Niamh Marriott, Junior Editor
The European Commission has granted marketing authorisation for AstraZeneca’s Brilique (ticagrelor) orodispersible tablets (ODT) as a new formulation...
